It’s a blunt question, but it deserves a direct answer: yes, untreated sleep apnea can contribute to premature death. Not as an acute event (you don’t simply stop breathing forever), but through cumulative damage to the cardiovascular system and other organs over years of untreated disease.
Understanding the mechanisms — and the evidence — makes the case for treatment far more compelling than “you should sleep better.”
The Primary Mortality Mechanisms
Cardiovascular Disease
This is the most significant pathway. Sleep apnea causes:
- Repeated oxygen desaturation throughout the night — brief but frequent drops in blood oxygen that stress the heart and vasculature
- Elevated blood pressure — the sympathetic nervous system surges during each apnea event; over time, this leads to sustained hypertension that persists into the daytime
- Cardiac arrhythmias — particularly atrial fibrillation, which is significantly more common in people with untreated sleep apnea
- Left ventricular hypertrophy — the heart wall thickens in response to chronic pressure overload
The Wisconsin Sleep Cohort Study — one of the longest-running sleep studies — found that people with severe untreated sleep apnea had a 3-fold higher risk of cardiovascular mortality compared to those without sleep apnea, after controlling for age, sex, and BMI.
Stroke
Sleep apnea is an independent risk factor for stroke. The mechanism includes:
- Nocturnal hypertension spikes
- Increased platelet aggregation (blood clotting tendency)
- Reduced cerebral oxygen delivery
- Cardiac arrhythmias that can cause emboli
Research finds that sleep apnea patients have roughly twice the stroke risk of matched controls.
Type 2 Diabetes and Metabolic Syndrome
The connections between sleep apnea, insulin resistance, and metabolic syndrome are well established (see our article on snoring and diabetes). Metabolic syndrome — a cluster of conditions including abdominal obesity, hypertension, elevated blood sugar, and abnormal cholesterol — dramatically elevates cardiovascular risk and all-cause mortality.
Motor Vehicle and Workplace Accidents
Excessive daytime sleepiness from poor sleep is a direct mortality risk through a different mechanism. People with untreated sleep apnea are 2–7 times more likely to be involved in motor vehicle accidents. Occupational accidents from impaired alertness add to this risk.
The Mortality Numbers
A landmark study published in Sleep found that:
- Men aged 40–70 with severe untreated sleep apnea had a 19% mortality rate over 18 years
- Matched controls without sleep apnea had a 4% mortality rate over the same period
The relationship was dose-dependent: mortality risk scaled with apnea severity.
Importantly, treatment eliminated most of this excess mortality. Patients who used CPAP consistently showed mortality rates similar to people without sleep apnea.
How Serious Does It Need to Be?
Mild sleep apnea carries much lower mortality risk than severe apnea. But even mild-to-moderate sleep apnea meaningfully elevates hypertension risk and daytime impairment.
The AHI (Apnea-Hypopnea Index) categories:
- Mild: 5–14 events per hour
- Moderate: 15–29 events per hour
- Severe: 30+ events per hour
Severe sleep apnea carries the most significant mortality risk. But given that most people with sleep apnea are undiagnosed and therefore untreated — and given that CPAP or alternative treatments effectively eliminate this excess risk — the argument for diagnosis is strong even at mild severity.
Diagnosing Sleep Apnea
If you’re concerned about sleep apnea, the path to diagnosis is:
- Talk to your doctor about symptoms — snoring, witnessed apneas, morning headaches, excessive daytime sleepiness
- Complete a sleep study — either a polysomnography (attended, in a sleep lab) or a home sleep apnea test (portable, at-home monitoring)
- Receive an AHI score that classifies severity and guides treatment decisions
Home sleep tests have improved dramatically in accuracy and are now standard for diagnosing uncomplicated obstructive sleep apnea. They’re more accessible and less expensive than lab studies.
Treatment Options
Effective treatment dramatically reduces the mortality risk associated with sleep apnea:
- CPAP — most effective for moderate-to-severe OSA; reduces cardiovascular events, blood pressure, and mortality risk
- Mandibular advancement devices — effective for mild-to-moderate OSA; solid evidence for blood pressure reduction
- Inspire therapy — for CPAP-intolerant patients; improving evidence base
- Weight loss — can resolve sleep apnea in overweight patients and is the only intervention that can produce cure rather than management
- Surgery — for specific anatomical contributors
The Bottom Line
Sleep apnea can and does contribute to premature death — primarily through cardiovascular disease, stroke, and accidents caused by impaired alertness. The excess mortality is substantial but largely preventable: people who treat their sleep apnea effectively see their mortality risk approach that of the general population.
If you snore loudly, feel unrested despite sleeping enough hours, or have been told you stop breathing during sleep, get evaluated. A sleep study is a straightforward test. The consequences of not doing it are not.